↓ Skip to main content
Embed badge What is this page?

Productivity and deadweight losses due to relapses of schizophrenia in Japan

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
3 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
20 Mendeley

What is this page?

Summary Twitter Facebook Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Productivity and deadweight losses due to relapses of schizophrenia in Japan
Published in
Neuropsychiatric Disease and Treatment, May 2017
DOI 10.2147/ndt.s138033
Pubmed ID
28553120
Authors

Yusuke Nakamura, Jörg Mahlich

Abstract

No study has examined the financial impact of relapses on schizophrenia from the perspective of Japanese society. This study aimed to estimate the societal costs in Japan caused by the relapses of schizophrenia. The societal costs in Japan in 2013 due to relapses of schizophrenia were estimated by summing the productivity loss and deadweight loss caused by schizophrenia relapses in 2013. Deterministic sensitivity analysis was conducted for deadweight loss rate, relapse rate, and patient income. Japan incurred JPY 55,039 million societal costs because of relapses in 2013. This consists of JPY 3,990 million for productivity loss and JPY 51,049 million for deadweight loss. Rate of deadweight loss is the most significant cost driver in the sensitivity analysis. Relapses of schizophrenia could generate huge amount of societal costs by reducing labor productivity and economic efficiency. To curb these costs, relapse prevention is desired in treating schizophrenia.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 25%
Researcher 4 20%
Lecturer > Senior Lecturer 2 10%
Student > Ph. D. Student 2 10%
Student > Bachelor 1 5%
Other 1 5%
Unknown 5 25%
Readers by discipline Count As %
Psychology 3 15%
Nursing and Health Professions 2 10%
Medicine and Dentistry 2 10%
Economics, Econometrics and Finance 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 2 10%
Unknown 9 45%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2017.
All research outputs
#14,063,221
of 22,973,051 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,410
of 2,993 outputs
Outputs of similar age
#167,385
of 310,772 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#31
of 78 outputs
Altmetric has tracked 22,973,051 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,993 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,772 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.

This page is provided by Altmetric.